The Controversial Role of Intestinal Mast Cells in Colon Cancer

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2023 Feb 11

PMID 36766801

Authors

Rosa Molfetta

Rossella Paolini

Affiliations

Soon will be listed here.

Abstract

Mast cells are tissue-resident sentinels involved in large number of physiological and pathological processes, such as infection and allergic response, thanks to the expression of a wide array of receptors. Mast cells are also frequently observed in a tumor microenvironment, suggesting their contribution in the transition from chronic inflammation to cancer. In particular, the link between inflammation and colorectal cancer development is becoming increasingly clear. It has long been recognized that patients with inflammatory bowel disease have an increased risk of developing colon cancer. Evidence from experimental animals also implicates the innate immune system in the development of sporadically occurring intestinal adenomas, the precursors to colorectal cancer. However, the exact role of mast cells in tumor initiation and growth remains controversial: mast cell-derived mediators can either exert pro-tumorigenic functions, causing the progression and spread of the tumor, or anti-tumorigenic functions, limiting the tumor's growth. Here, we review the multifaceted and often contrasting findings regarding the role of the intestinal mast cells in colon cancer progression focusing on the molecular pathways mainly involved in the regulation of mast cell plasticity/functions during tumor progression.

Citing Articles

Beyond the "Master" Role in Allergy: Insights into Intestinal Mast Cell Plasticity and Gastrointestinal Diseases.

Molfetta R, Carnevale A, Marangio C, Putro E, Paolini R Biomedicines. 2025; 13(2).

PMID: 40002733 PMC: 11853218. DOI: 10.3390/biomedicines13020320.

Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.

Song X, Jiao J, Qin J, Zhang W, Qin W, Ma S Front Immunol. 2025; 15():1494025.

PMID: 39840068 PMC: 11747552. DOI: 10.3389/fimmu.2024.1494025.

Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.

Nishi M, Yamashita S, Takasu C, Wada Y, Yoshikawa K, Tokunaga T BMC Cancer. 2025; 25(1):99.

PMID: 39825280 PMC: 11740561. DOI: 10.1186/s12885-025-13458-9.

Non-Thermal Atmospheric Pressure Plasma as an Adjunct to Intestinal Anastomosis: A Pilot Study on Preventing Anastomotic Leaks.

Betancourt-Angeles M, Lopez-Callejas R, Berrones-Stringel G, Jaramillo-Martinez C, Navarro-Luna B, Rodriguez-Mendez B Life (Basel). 2024; 14(11).

PMID: 39598248 PMC: 11595499. DOI: 10.3390/life14111450.

Identification of a PANoptosis-related prognostic model in triple-negative breast cancer, from risk assessment, immunotherapy, to personalized treatment.

Chen J, Gong R, Teng C, Lin Y, Shen L, Lin Z Heliyon. 2024; 10(19):e38732.

PMID: 39430460 PMC: 11489348. DOI: 10.1016/j.heliyon.2024.e38732.

References

Tan S, Fan Y, Luo H, Shen Z, Guo Y, Zhao L . Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol. 2005; 11(8):1210-4. PMC: 4250716. DOI: 10.3748/wjg.v11.i8.1210. View

Gurish M, Austen K . Developmental origin and functional specialization of mast cell subsets. Immunity. 2012; 37(1):25-33. DOI: 10.1016/j.immuni.2012.07.003. View

Quezada-Marin J, Lam A, Ochiai A, Odze R, Washington K, Fukayama M . Gastrointestinal tissue-based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours. Histopathology. 2020; 77(3):340-350. DOI: 10.1111/his.14120. View

Reber L, Sibilano R, Mukai K, Galli S . Potential effector and immunoregulatory functions of mast cells in mucosal immunity. Mucosal Immunol. 2015; 8(3):444-63. PMC: 4739802. DOI: 10.1038/mi.2014.131. View

Saadalla A, Osman A, Gurish M, Dennis K, Blatner N, Pezeshki A . Mast cells promote small bowel cancer in a tumor stage-specific and cytokine-dependent manner. Proc Natl Acad Sci U S A. 2018; 115(7):1588-1592. PMC: 5816178. DOI: 10.1073/pnas.1716804115. View

McDermott J, Bartram R, Knight P, Miller H, Garrod D, Grencis R . Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci U S A. 2003; 100(13):7761-6. PMC: 164661. DOI: 10.1073/pnas.1231488100. View

Cristinziano L, Poto R, Criscuolo G, Ferrara A, Galdiero M, Modestino L . IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors. Cells. 2021; 10(1). PMC: 7828291. DOI: 10.3390/cells10010145. View

Corren J, Ziegler S . TSLP: from allergy to cancer. Nat Immunol. 2019; 20(12):1603-1609. DOI: 10.1038/s41590-019-0524-9. View

Lee J, Jeon Y, Xin M, Lim J, Lee Y, Kim D . Mast cell modulates tumorigenesis caused by repeated bowel inflammation condition in azoxymethane/dextran sodium sulfate-induced colon cancer mouse model. Biochem Biophys Rep. 2022; 30:101253. PMC: 8976097. DOI: 10.1016/j.bbrep.2022.101253. View

10.

Gendrin C, Shubin N, Boldenow E, Merillat S, Clauson M, Power D . Mast cell chymase decreases the severity of group B Streptococcus infections. J Allergy Clin Immunol. 2017; 142(1):120-129.e6. PMC: 5847414. DOI: 10.1016/j.jaci.2017.07.042. View

11.

Knight P, Wright S, Lawrence C, Paterson Y, Miller H . Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J Exp Med. 2000; 192(12):1849-56. PMC: 2213497. DOI: 10.1084/jem.192.12.1849. View

12.

Schemann M, Camilleri M . Functions and imaging of mast cell and neural axis of the gut. Gastroenterology. 2013; 144(4):698-704.e4. PMC: 3922647. DOI: 10.1053/j.gastro.2013.01.040. View

13.

Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, Tsujikawa T . Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol. 2010; 45(10):999-1007. DOI: 10.1007/s00535-010-0245-1. View

14.

Chan A, Giovannucci E . Primary prevention of colorectal cancer. Gastroenterology. 2010; 138(6):2029-2043.e10. PMC: 2947820. DOI: 10.1053/j.gastro.2010.01.057. View

15.

Nagtegaal I, Odze R, Klimstra D, Paradis V, Rugge M, Schirmacher P . The 2019 WHO classification of tumours of the digestive system. Histopathology. 2019; 76(2):182-188. PMC: 7003895. DOI: 10.1111/his.13975. View

16.

Tsujii K, Andoh T, Lee J, Kuraishi Y . Activation of proteinase-activated receptors induces itch-associated response through histamine-dependent and -independent pathways in mice. J Pharmacol Sci. 2008; 108(3):385-8. DOI: 10.1254/jphs.08200sc. View

17.

Maywald R, Doerner S, Pastorelli L, De Salvo C, Benton S, Dawson E . IL-33 activates tumor stroma to promote intestinal polyposis. Proc Natl Acad Sci U S A. 2015; 112(19):E2487-96. PMC: 4434739. DOI: 10.1073/pnas.1422445112. View

18.

Schwarzer M, Hermanova P, Srutkova D, Golias J, Hudcovic T, Zwicker C . Germ-Free Mice Exhibit Mast Cells With Impaired Functionality and Gut Homing and Do Not Develop Food Allergy. Front Immunol. 2019; 10:205. PMC: 6379318. DOI: 10.3389/fimmu.2019.00205. View

19.

Frossi B, Mion F, Tripodo C, Colombo M, Pucillo C . Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses. Trends Immunol. 2017; 38(9):648-656. DOI: 10.1016/j.it.2017.04.001. View

20.

Sedhom M, Pichery M, Murdoch J, Foligne B, Ortega N, Normand S . Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut. 2012; 62(12):1714-23. PMC: 3841767. DOI: 10.1136/gutjnl-2011-301785. View